Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
3
×
clinical trials
3
×
life sciences
national blog main
national top stories
new york blog main
amgen
biohaven
biotech
boston blog main
boston top stories
eli lilly
fda
migraine
national
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
abbvie
alder biopharmaceutical
american academy of neurology
atogepant
bob azelby
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
bristol-myers squibb
calcitonin gene-related peptide
cgpr
clinical data
detroit blog main
detroit top stories
drugs
eptinezumab
erenumab
europe blog main
fremanezumab
What
new
3
×
approved
class
drug
fda
migraine
adults
allergan
approval
arguments
big
commercialized
companies
competitors
data
decades
disease
drugs
fatty
horizon
intercept
known
liver
make
marketed
medicine
medicines
meeting
monday
nash
neuro
nod
nonalcoholic
oral
pill
potential
steatohepatitis
therapies
track
treat
Language
unset
Current search:
allergan
×
new
×
" clinical trials "
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug